FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 338:1169-1173 April 23, 1998 Number 17 Next

	Full Text PDF Editorial by Büller, H. Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Several small studies have indicated an association between deep venous thrombosis or pulmonary embolism and a subsequent diagnosis of cancer, but the subject is controversial.

Methods We conducted a nationwide study of a cohort of patients with deep venous thrombosis or pulmonary embolism that was drawn from the Danish National Registry of Patients for the years 1977 through 1992. The occurrence of cancer in the cohort was determined by linkage to the Danish Cancer Registry. The expected number of cancer cases was estimated on the basis of national age-, sex-, and site-specific incidence rates.

Results A total of 15,348 patients with deep venous thrombosis and 11,305 patients with pulmonary embolism were identified. We observed 1737 cases of cancer in the cohort with deep venous thrombosis, as compared with 1372 expected cases (standardized incidence ratio, 1.3; 95 percent confidence interval, 1.21 to 1.33). Among the patients with pulmonary embolism, the standardized incidence ratio was 1.3, with a 95 percent confidence interval of 1.22 to 1.41. The risk was substantially elevated only during the first six months of follow-up and declined rapidly thereafter to a constant level slightly above 1.0 one year after the thrombotic event. Forty percent of the patients given a diagnosis of cancer within one year after hospitalization for thromboembolism had distant metastases at the time of the diagnosis of cancer. There were strong associations with several cancers, most pronounced for those of the pancreas, ovary, liver (primary hepatic cancer), and brain.

Conclusions An aggressive search for a hidden cancer in a patient with a primary deep venous thrombosis or pulmonary embolism is not warranted.

Source Information

From the Danish Epidemiology Science Center at the Department of Epidemiology and Social Medicine (H.T.S., F.H.S.), and the Department of Internal Medicine V (H.T.S.), University of Aarhus, Aarhus; the Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen (L.M., J.H.O.); and the Department of Internal Medicine M, Aalborg Hospital, Aalborg (G.L.N.) — all in Denmark.

Address reprint requests to Dr. Sørensen at the Danish Epidemiology Science Center, University of Aarhus, Høegh-Guldbergs Gade 10, DK-8000 Aarhus C, Denmark.

Full Text of this Article

Related Letters:

Cancer and Venous Thromboembolism
Hilson A. J.W., Sørensen H. T., MellemkjÆr L., Olsen J. H.
Extract | Full Text  
N Engl J Med 1998; 339:703, Sep 3, 1998. Correspondence

Venous Thromboembolism and Cancer
Eikelboom J. W., Mehta S. R., Hughes-Davies T.H., Roychowdhury D., Zacharski L. R., Ornstein D. L., Schulman S., Lindmarker P.
Extract | Full Text  
N Engl J Med 2000; 343:1337-1338, Nov 2, 2000. Correspondence

This article has been cited by other articles:

• Khorana, A. A., Streiff, M. B., Farge, D., Mandala, M., Debourdeau, P., Cajfinger, F., Marty, M., Falanga, A., Lyman, G. H. (2009). Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action. JCO 27: 4919-4926 [Abstract] [Full Text]  
• Kuderer, N. M., Ortel, T. L., Francis, C. W. (2009). Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival. JCO 27: 4902-4911 [Abstract] [Full Text]  
• Boccaccio, C., Comoglio, P. M. (2009). Genetic Link Between Cancer and Thrombosis. JCO 27: 4827-4833 [Abstract] [Full Text]  
• McCann, J. C, Ames, B. N (2009). Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?. Am. J. Clin. Nutr. 90: 889-907 [Abstract] [Full Text]  
• Verdu, A, Maestre, A, Lopez, P, Gil, V, Martin-Hidalgo, A, Castano, J A (2009). Clinical pathways as a healthcare tool: design, implementation and assessment of a clinical pathway for lower-extremity deep venous thrombosis. Qual Saf Health Care 18: 314-320 [Abstract] [Full Text]  
• Perrier, A. (2009). Review: 1-year risk of previously undiagnosed cancer is 6.3% in patients with newly diagnosed venous thromboembolism. Evid. Based Med. 14: 57-57 [Full Text]  
• BABU, B., CARMAN, T. L. (2009). Cancer and clots: All cases of venous thromboembolism are not treated the same. Cleveland Clinic Journal of Medicine 76: 129-135 [Abstract] [Full Text]  
• Moores, L. K. (2009). Pulmonary Vascular Diseases. ACCP Pulmonary Med Brd Rev 25: 21-38 [Full Text]  
• Kristinsson, S. Y., Fears, T. R., Gridley, G., Turesson, I., Mellqvist, U.-H., Bjorkholm, M., Landgren, O. (2008). Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood 112: 3582-3586 [Abstract] [Full Text]  
• Carrier, M., Le Gal, G., Wells, P. S., Fergusson, D., Ramsay, T., Rodger, M. A. (2008). Systematic Review: The Trousseau Syndrome Revisited: Should We Screen Extensively for Cancer in Patients with Venous Thromboembolism?. ANN INTERN MED 149: 323-333 [Abstract] [Full Text]  
• Dalal, P U (2008). Non-metastatic manifestations of cancer in the chest. Imaging 20: 194-204 [Abstract] [Full Text]  
• el-Shami, K., Griffiths, E., Streiff, M. (2007). Nonbacterial Thrombotic Endocarditis in Cancer Patients: Pathogenesis, Diagnosis, and Treatment. The Oncologist 12: 518-523 [Abstract] [Full Text]  
• Paz-Priel, I., Long, L., Helman, L. J., Mackall, C. L., Wayne, A. S. (2007). Thromboembolic Events in Children and Young Adults With Pediatric Sarcoma. JCO 25: 1519-1524 [Abstract] [Full Text]  
• Gulley, J. L., Parnes, H. L., Wright, J., Dahut, W. L. (2006). Early Treatment Gets the Benefit. JCO 24: 5172-5173 [Full Text]  
• Fennerty, A (2006). Venous thromboembolic disease and cancer.. Postgrad. Med. J. 82: 642-648 [Abstract] [Full Text]  
• Gerber, D. E., Grossman, S. A., Streiff, M. B. (2006). Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors. JCO 24: 1310-1318 [Abstract] [Full Text]  
• Lee, A. Y. Y. (2006). Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological Mechanisms. ASH Education Book 2006: 438-443 [Abstract] [Full Text]  
• White, R. H., Chew, H. K., Zhou, H., Parikh-Patel, A., Harris, D., Harvey, D., Wun, T. (2005). Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528 693 Adults. Arch Intern Med 165: 1782-1787 [Abstract] [Full Text]  
• Falanga, A., Zacharski, L. (2005). Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 16: 696-701 [Abstract] [Full Text]  
• Prandoni, P. (2005). Acquired Risk Factors for Venous Thromboembolism in Medical Patients. ASH Education Book 2005: 458-461 [Abstract] [Full Text]  
• Castelli, R., Porro, F., Tarsia, P. (2004). The heparins and cancer: review of clinical trials and biological properties. Vasc Med 9: 205-213 [Abstract]  
• Schattner, A. (2004). Mesothelioma and venous thrombosis. CMAJ 171: 11-12 [Full Text]  
• Otten, H.-M. M. B., Mathijssen, J., ten Cate, H., Soesan, M., Inghels, M., Richel, D. J., Prins, M. H. (2004). Symptomatic Venous Thromboembolism in Cancer Patients Treated With Chemotherapy: An Underestimated Phenomenon. Arch Intern Med 164: 190-194 [Abstract] [Full Text]  
• Lopez, J. A., Kearon, C., Lee, A. Y.Y. (2004). Deep Venous Thrombosis. ASH Education Book 2004: 439-456 [Abstract] [Full Text]  
• Horlander, K. T., Mannino, D. M., Leeper, K. V. (2003). Pulmonary Embolism Mortality in the United States, 1979-1998: An Analysis Using Multiple-Cause Mortality Data. Arch Intern Med 163: 1711-1717 [Abstract] [Full Text]  
• Lee, A. Y.Y., Levine, M. N. (2003). Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation 107: I-17-21 [Abstract] [Full Text]  
• (2003). British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 58: 470-483 [Full Text]  
• LaPorte, D., Farber, S., Sorin, S., Wahba, S., Daneels, E., Korzenko, A., Kopes-Kerr, C. P. (2003). When Deep Venous Thrombosis Fails to Respond to Therapy. J Am Board Fam Med 16: 246-250 [Abstract] [Full Text]  
• Ozturk, M., Sengul, N., Dagli, M., Kosar, A., Bavbek, N. (2003). Global Fibrinolytic Capacity in Colorectal Cancer: A New Clue to Occult Fibrinolysis. CLIN APPL THROMB HEMOST 9: 151-154 [Abstract]  
• Deitcher, S. R, Gomes, M. P. (2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 8: 33-46 [Abstract]  
• Yoon, K H, Wong, A, Shakespeare, T, Sivalingam, P (2003). High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12: 112-116 [Abstract]  
• Naschitz, J. E., Kovaleva, J., Shaviv, N., Rennert, G., Yeshurun, D. (2003). Vascular Disorders Preceding Diagnosis of Cancer: Distinguishing the Causal Relationship based on Bradford-Hill Guidelines. ANGIOLOGY 54: 11-17 [Abstract]  
• Tsopanoglou, N. E., Andriopoulou, P., Maragoudakis, M. E. (2002). On the mechanism of thrombin-induced angiogenesis: involvement of alpha vbeta 3-integrin. Am. J. Physiol. Cell Physiol. 283: C1501-C1510 [Abstract] [Full Text]  
• Samuels, M. A., King, M. E., Balis, U. (2002). Case 31-2002 - A 61-Year-Old Man with Headache and Multiple Infarcts. NEJM 347: 1187-1194 [Full Text]  
• Hambleton, J., Leung, L. L., Levi, M. (2002). Coagulation: Consultative Hemostasis. ASH Education Book 2002: 335-352 [Abstract] [Full Text]  
• Girolami, A. (2001). Idiopathic Deep Vein Thrombosis and Subsequent Cancer: Suggestions for a Patient-Oriented and Practical Approach. CLIN APPL THROMB HEMOST 7: 321-324 [Abstract]  
• Fennerty, T. (2001). Screening for cancer in venous thromboembolic disease. BMJ 323: 704-705 [Full Text]  
• (2001). A case of venous thrombosis. Postgrad. Med. J. 77: 606-606 [Full Text]  
• Wilson, K., Guardino, J., Shapira, O. M. (2001). Pulmonary Tumor Embolism as a Presenting Feature of Cavoatrial Hepatocellular Carcinoma. Chest 119: 657-658 [Abstract] [Full Text]  
• Sorensen, H. T., Mellemkjar, L., Olsen, J. H., Baron, J. A. (2000). Prognosis of Cancers Associated with Venous Thromboembolism. NEJM 343: 1846-1850 [Abstract] [Full Text]  
• Eikelboom, J. W., Mehta, S. R., Hughes-Davies, T.H., Roychowdhury, D., Zacharski, L. R., Ornstein, D. L., Schulman, S., Lindmarker, P. (2000). Venous Thromboembolism and Cancer. NEJM 343: 1337-1338 [Full Text]  
• (2000). Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21: 1301-1336  
• Schulman, S., Lindmarker, P., The Duration of Anticoagulation Trial, (2000). Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism. NEJM 342: 1953-1958 [Abstract] [Full Text]  
• Zielinski, C. C., Hejna, M. (2000). Warfarin for Cancer Prevention. NEJM 342: 1991-1993 [Full Text]  
• Tsopanoglou, N. E., Maragoudakis, M. E. (1999). On the Mechanism of Thrombin-induced Angiogenesis. POTENTIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR ACTIVITY ON ENDOTHELIAL CELLS BY UP-REGULATION OF ITS RECEPTORS. J. Biol. Chem. 274: 23969-23976 [Abstract] [Full Text]  
• Kakkar, A K, Williamson, R C N (1999). Antithrombotic therapy in cancer. BMJ 318: 1571-1572 [Full Text]  
• Hilson, A. J.W., Sorensen, H. T., MellemkjAer, L., Olsen, J. H. (1998). Cancer and Venous Thromboembolism. NEJM 339: 703-703 [Full Text]  
• (1998). Cancer and Venous Thromboembolism Revisited. JWatch General 1998: 3-3 [Full Text]  
• Buller, H., ten Cate, J. W. (1998). Primary Venous Thromboembolism and Cancer Screening. NEJM 338: 1221-1222 [Full Text]